Abstract
CAR T cell therapy successes are challenged by several mechanisms of resistance including the development of dysfunctional states such as exhaustion. The features of CAR T cell exhaustion, its role in limiting the efficacy of CAR T therapy in both liquid and solid malignancies, and potential strategies to overcome it are discussed.
Original language | English |
---|---|
Pages (from-to) | 885-888 |
Number of pages | 4 |
Journal | Cancer Cell |
Volume | 39 |
Issue number | 7 |
DOIs | |
State | Published - 12 Jul 2021 |